This pharmaceutical province, or more than 700 kinds of drugs out of health insurance!

In accordance with the requirements of the Interim Measures for the Administration of Essential Medical Insurance Drugs, drugs that mainly play a tonic role; medicines containing national precious and endangered wildlife herbs; health care drugs; preventive vaccines and contraceptives; drugs that mainly play a role in enhancing sexual function, treating hair loss, weight loss, beauty, smoking cessation, alcohol withdrawal, etc.; and eight types of drugs that cannot be charged separately will not be allowed to enter the drug catalogue for reasons such as being included in the treatment program.
the Measures will come into effect on 1 September.
these eight types of drugs are not obvious effect, the composition of many similar drugs.
it is understood that the drug catalogue is adjusted annually in principle.
past, tonic drugs, health care drugs, auxiliary drugs, etc. accounted for a larger proportion of the drug catalog, and clinically necessary, safe and effective, affordable drug space is limited.
with the transfer of these eight types of non-essential drugs, it is conducive to the inclusion of more clinically necessary good drugs, new drugs, better protect the patient's drug demand, reduce the burden of patients' medication.
, the industry believes that the adjustment of the health care directory is conducive to precise protection.
, for example, the preventive vaccine will be available, but therapeutic vaccines are not excluded, hepatitis B therapeutic vaccines and other therapeutic vaccines can play a greater role in the treatment of products can still be included.
, the first category of vaccines in preventive vaccines is free of charge within the national immunization programme, and the second type of vaccine is a self-cost vaccine and can be guaranteed through ad hoc initiatives.
it is worth mentioning that, from September 1st, zhejiang Provincial Health Insurance Bureau issued the "Zhejiang Province to enhance the centralized procurement platform function to promote the full coverage of medical insurance drug payment standards reform program" will also be formally implemented.
the implementation of the drug purchase platform in Zhejiang Province, the number of drugs traded online will increase from 144,000 to 171,000.
programme also made it clear that a product exit mechanism should be established.
For products that are unable to supply and are not traded for more than 1 year due to various reasons, and have alternative products with other drugs, they shall be withdrawn upon application by the enterprise, and the provincial drug procurement center shall be evaluated and audited without affecting clinical drug use.
not accept the product being re-networked within two years of its exit.
to the online trading products within the platform, the establishment of a market-oriented exit mechanism, through the implementation of volume procurement, the implementation of small units of the same product bidding, the formulation of a common list of medical insurance payment standards and other ways to withdraw.
understood that at present, Zhejiang Province medical insurance drugs have entered the adjustment stage, in the above two documents, Zhejiang Province may have more than 700 kinds of drugs out of health insurance.
, Zhejiang Province has been implementing a centralized drug procurement system for more than 10 years, which can basically meet the needs of clinical and mass drug use.
But the traditional drug procurement and medical insurance payment system there are certain short boards, including pharmaceutical procurement platform there is a medical insurance drug online trading varieties are not complete, product price competition is not sufficient, but also because private medical institutions and retail pharmacies are not included in the scope of centralized recruitment, to a certain extent, there are some non-winning drug prices falsely high problem, increasing the burden of the insured masses and medical insurance funds.
the overall goal of this reform is to improve the bidding mechanism and complement the short board of the system by integrating the functions of drug recruitment and medical insurance payment.
to expand the procurement coverage of medicines in the health insurance catalogue and to safeguard the demand for medical insurance drugs on a larger scale.